John C. Hamel
Scripps Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by John C. Hamel.
Nature Cell Biology | 2005
Andrew Jakymiw; Shangli Lian; Theophany Eystathioy; Songqing Li; Minoru Satoh; John C. Hamel; Marvin J. Fritzler; Edward K. L. Chan
The GW182 RNA-binding protein was initially shown to associate with a specific subset of mRNAs and to reside within discrete cytoplasmic foci named GW bodies (GWBs). GWBs are enriched in proteins that are involved in mRNA degradation. Recent reports have shown that exogenously introduced human Argonaute-2 (Ago2) is also enriched in GWBs, indicating that RNA interference function may be somehow linked to these structures. In this report, we demonstrate that endogenous Ago2 and transfected small interfering RNAs (siRNAs) are also present within these same cytoplasmic bodies and that the GW182 protein interacts with Ago2. Disruption of these cytoplasmic foci in HeLa cells interferes with the silencing capability of a siRNA that is specific to lamin-A/C. Our data support a model in which GW182 and/or the microenvironment of the cytoplasmic GWBs contribute to the RNA-induced silencing complex and to RNA silencing.
Journal of Clinical Investigation | 1991
Edward K. L. Chan; John C. Hamel; Jill P. Buyon; Eng M. Tan
Serum SS-A/Ro autoantibodies are commonly found in patients with Sjogrens syndrome, systemic lupus erythematosus, neonatal lupus, and subacute cutaneous lupus. Two proteins of 60 and 52 kD have been described as targets for these autoantibodies. To define the 52-kD component unambiguously, cDNA clones were isolated from human HepG2 and MOLT-4 cell cDNA libraries. The identity of cDNA was established by (a) the specificity of the antibody affinity purified from the recombinant protein, (b) the reactivity of the purified recombinant protein with prototype SS-A/Ro sera in immunoblot and ELISA, and (c) two-dimensional gel comigration of MOLT-4 cell 52-kD protein and the recombinant protein. A 1.9-kb cDNA encoded the complete 52-kD protein containing 475 amino acids (Mr 54,082). Putative zinc-finger domains and a leucine zipper motif were identified in the amino-terminal half of the 52-kD protein, implicating its possible association with DNA/RNA. Sequence homology detected between the 52-kD protein and human ret transforming protein, and mouse T cell gene expression down-regulatory protein rpt-1, may provide leads to the functional role of the 52-kD protein in addition to the possibility that these proteins might constitute members of a subfamily of finger proteins.
EMBO Reports | 2006
Kaleb M. Pauley; Theophany Eystathioy; Andrew Jakymiw; John C. Hamel; Marvin J. Fritzler; Edward K. L. Chan
GW bodies (GWBs), or mammalian P bodies, proposed to be involved in messenger RNA storage and/or degradation, have recently been linked to RNA interference and microRNA (miRNA) processing. We report that endogenous let‐7 miRNA co‐precipitates with the GW182 protein complex. In addition, knockdown of two proteins, Drosha and its protein partner DGCR8, which are vital to the generation of mature miRNA, results in the loss of GWBs. Subsequent introduction of short interference RNA specific to lamin A/C is accompanied by reassembly of GWBs and concurrent knockdown of lamin A/C protein. Taken together, these studies show that miRNAs are crucial components in GWB formation.
Cell Cycle | 2006
Shangli Lian; Andrew Jakymiw; Theophany Eystathioy; John C. Hamel; Marvin J. Fritzler; Edward K. L. Chan
GW bodies (GWBs) are cytoplasmic foci initially identified through the use of an autoimmuneserum targeting the marker protein, GW182. GWBs were first considered as both storagecenters for a specific subset of mRNAs and degradation sites for mRNAs. Interestingly, theyare known to vary in size and number throughout the cell cycle and are largest in size and mostabundant in number during the late S and G2 phases. Recent studies have linked RNAinterference to GWBs, in that disruption or disassembly of GWBs was demonstrated to impairsiRNA and miRNA silencing activity. As miRNAs are implicated in the regulation of cellcycle progression and cell proliferation, it is very likely that GWBs, the critical intracellularstructures for miRNA function, may very well be also linked to this cellular process.
Journal of Autoimmunity | 2012
K. Michael Pollard; Per Hultman; Christopher B. Toomey; David M. Cauvi; Hal M. Hoffman; John C. Hamel; Dwight H. Kono
IFN-γ is essential for idiopathic and murine mercury-induced systemic autoimmunity (mHgIA), and heterozygous IFN-γ(+/-) mice also exhibit reduced disease. This suggests that blocking specific IFN-γ-related pathways that may only partially inhibit IFN-γ production or function will also suppress autoimmunity. To test this hypothesis, mice deficient in genes regulating IFN-γ expression (Casp1, Nlrp3, Il12a, Il12b, Stat4) or function (Ifngr1, Irf1) were examined for mHgIA susceptibility. Absence of either Ifngr1 or Irf1 resulted in a striking reduction of disease, while deficiency of genes promoting IFN-γ expression had modest to no effect. Furthermore, both Irf1- and Ifng-deficiency only modestly reduced the expansion of CD44(hi) and CD44(hi)CD55(lo) CD4(+) T cells, indicating that they are not absolutely required for T cell activation. Thus, there is substantial redundancy in genes that regulate IFN-γ expression in contrast to those that mediate later signaling events. These findings have implications for the therapeutic targeting of IFN-γ pathways in systemic autoimmunity.
Arthritis & Rheumatism | 1997
Kevin J. Griffith; Edward K. L. Chan; Chien-Cheng Lung; John C. Hamel; Xiaoying Guo; Kiyomitsu Miyachi; Marvin J. Fritzler
Journal of Experimental Medicine | 1993
M. J. Fritzler; John C. Hamel; R. L. Ochs; Edward K. L. Chan
Journal of Biological Chemistry | 1995
Marvin J. Fritzler; Chien-Cheng Lung; John C. Hamel; Kevin J. Griffith; Edward K. L. Chan
Journal of Immunology | 1994
Jill P. Buyon; Seth G. Slade; John D. Reveille; John C. Hamel; Edward K. L. Chan
Journal of Experimental Medicine | 1995
Edward K. L. Chan; F. Di Donato; John C. Hamel; Chung-E Tseng; Jill P. Buyon